About David Persing
David Persing is executive vice president and chief medical officer at Cepheid, where he has worked since 2005. His work there has focused on diagnostic tests for infections and cancer.
He earned his MD and PhD degrees in 1988 and completed laboratory medicine residency training at Yale. In the early 1990s, he helped design and build Mayo Clinic's first PCR reference laboratory. From 2017 through 2023, Persing served as chief scientific officer for Danaher's Diagnostics platform after Danaher acquired Cepheid. He is a director of Inflammatix, which develops rapid tests that read immune responses to help physicians diagnose acute infections and sepsis.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name David Persing in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Persing works with at each company, as listed on that company's latest Form D.



